73 related articles for article (PubMed ID: 1576867)
1. AGNORS in skin lesions of cutaneous malignant lymphomas and pseudolymphomas.
Qiu BS; Xu LZ; Kong JC; Chen HL; Tao LD
Chin Med J (Engl); 1992 Jan; 105(1):30-3. PubMed ID: 1576867
[TBL] [Abstract][Full Text] [Related]
2. DNA flow cytometry from paraffin-embedded tissue in diagnosis of cutaneous malignant lymphomas and pseudolymphomas.
Qiu BS; Ni HZ
Chin Med J (Engl); 1993 Aug; 106(8):611-4. PubMed ID: 8222911
[TBL] [Abstract][Full Text] [Related]
3. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
Howat AJ; Wright AL; Cotton DW; Reeve S
Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
[TBL] [Abstract][Full Text] [Related]
4. Expression of proliferating cell nuclear antigen in cutaneous malignant lymphomas and lymphoid infiltrates.
Qiu BS; Luo JM
Chin Med J (Engl); 1994 Jul; 107(7):496-9. PubMed ID: 7956495
[TBL] [Abstract][Full Text] [Related]
5. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
[TBL] [Abstract][Full Text] [Related]
6. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
9. The expression of MUM1 in cutaneous T-cell lymphoproliferative disorders.
Wasco MJ; Fullen D; Su L; Ma L
Hum Pathol; 2008 Apr; 39(4):557-63. PubMed ID: 18234282
[TBL] [Abstract][Full Text] [Related]
10. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
11. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and severity of pruritus in cutaneous T cell lymphoma.
Vij A; Duvic M
Int J Dermatol; 2012 Aug; 51(8):930-4. PubMed ID: 22788808
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
14. Ichthyosiform eruptions in association with primary cutaneous T-cell lymphomas.
Morizane S; Setsu N; Yamamoto T; Hamada T; Nakanishi G; Asagoe K; Iwatsuki K
Br J Dermatol; 2009 Jul; 161(1):115-20. PubMed ID: 19416265
[TBL] [Abstract][Full Text] [Related]
15. Epidermal Langerhans cells in mycosis fungoides and Sézary syndrome.
Matejka M; Konrad K
Wien Klin Wochenschr; 1983 Dec; 95(23):847-52. PubMed ID: 6670281
[TBL] [Abstract][Full Text] [Related]
16. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
17. [Aggressive cutaneous T-cell lymphoma associated with the presence of Epstein-Barr virus. 2 cases].
Mouly F; Baccard M; Rybojad M; Lebbé C; Morinet F; Morel P
Ann Dermatol Venereol; 1996; 123(9):574-6. PubMed ID: 9615113
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance related proteins in primary cutaneous lymphomas.
van Haselen CW; Flens MJ; Scheper RJ; van der Valk P; Scheffer GL; Toonstra J; van Vloten WA
Adv Exp Med Biol; 1999; 457():119-31. PubMed ID: 10500787
[TBL] [Abstract][Full Text] [Related]
19. Immunopathology of cutaneous T-cell lymphomas.
Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
[TBL] [Abstract][Full Text] [Related]
20. Treatment of parapsoriasis en plaques, mycosis fungoides, and Sézary's syndrome with trioxsalen baths followed by ultraviolet light.
Fischer T; Skogh M
Acta Derm Venereol; 1979; 59(2):171-3. PubMed ID: 84498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]